1-5 of 5
Lars Kober
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

MAGNUS O. WIJKMAN, BRIAN CLAGGETT, RAFAEL DIAZ, HERTZEL C. GERSTEIN, LARS KOBER, ELDRIN LEWIS, ALDO P. MAGGIONI, EMIL WOLSK, DAVID AGUILAR, RHONDA BENTLEY-LEWIS, JOHN J. MCMURRAY, JEFFREY L. PROBSTFIELD, MATTHEW C. RIDDLE, JEAN-CLAUDE TARDIF, SCOTT SOLOMON, MARC A. PFEFFER
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1421-P
https://doi.org/10.2337/db20-1421-P
Published: 01 June 2020
View articletitled, 1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event
Meeting Abstracts

271-OR: ADA Presidents’ Select Abstract: Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF

SILVIO E. INZUCCHI, KIERAN DOCHERTY, LARS KOBER, MIKHAIL N. KOSIBOROD, FELIPE MARTINEZ, PIOTR PONIKOWSKI, MARC S. SABATINE, SCOTT SOLOMON, JAN BELOHLAVEK, MICHAEL BÖHM, CHERN-EN CHIANG, RUDOLF A. DE BOER, MIRTA DIEZ, ANDREJ DUKAT, CHARLOTTA E.A. LJUNGMAN, SUBODH VERMA, DAVID L. DEMETS, OLOF BENGTSSON, ANNA MARIA LANGKILDE, MIKAELA SJÖSTRAND, PARDEEP JHUND, JOHN J. MCMURRAY
Journal: Diabetes
Diabetes 2020;69(Supplement_1):271-OR
https://doi.org/10.2337/db20-271-OR
Published: 01 June 2020
View articletitled, 271-OR: ADA Presidents’ Select Abstract: Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF
Meeting Abstracts

1112-P: Does Background T2D Therapy Modify the Benefits of Dapagliflozin in Heart Failure? Analysis of the DAPA-HF Trial

KIERAN DOCHERTY, SILVIO E. INZUCCHI, MIKHAIL N. KOSIBOROD, LARS KOBER, ANNA MARIA LANGKILDE, FELIPE MARTINEZ, OLOF BENGTSSON, DAVID L. DEMETS, MIKAELA SJÖSTRAND, MARC S. SABATINE, SCOTT SOLOMON, PARDEEP JHUND, JOHN J. MCMURRAY
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1112-P
https://doi.org/10.2337/db20-1112-P
Published: 01 June 2020
View articletitled, 1112-P: Does Background T2D Therapy Modify the Benefits of Dapagliflozin in Heart Failure? Analysis of the DAPA-HF Trial
Journal Articles

Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients

Ulrik Madvig Mogensen, Tonny Jensen, Lars Køber, Henning Kelbæk, Anne Sophie Mathiesen, Ulrik Dixen, Peter Rossing, Jannik Hilsted, Klaus Fuglsang Kofoed
Journal: Diabetes
Diabetes 2012;61(7):1822–1830
https://doi.org/10.2337/db11-1235
Published: 15 June 2012
View articletitled, Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients
Open the PDF for Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients in another window
Journal Articles

Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease

Christian Rask-Madsen, Nikolaj Ihlemann, Thure Krarup, Erik Christiansen, Lars Kober, Caroline Nervil Kistorp, Christian Torp-Pedersen
Journal: Diabetes
Diabetes 2001;50(11):2611–2618
https://doi.org/10.2337/diabetes.50.11.2611
Published: 01 November 2001
View articletitled, Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease
Open the PDF for Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease in another window